From the Desk of Steve Strazza and Alfonso Depablos
The largest insider buy on today’s list comes in a series of Form 4 filings by Gilead Sciences.
The American biopharmaceutical company revealed a purchase of roughly $320 million in Arcus Biosciences Inc $RCUS, increasing its ownership stake to 40%.
From the Desk of Steve Strazza and Alfonso Depablos
The largest insider buy on today’s list comes in a series of Form 4 filings by Elias Sabo, director and CEO of Compass Group Diversified Holdings LLC $CODI.
Sabo reported an aggregate CODI purchase worth roughly $2 million.